Laser Photocoagulation of Subfoveal Recurrent Neovascular Lesions in Age-Related Macular Degeneration: Results of a Randomized Clinical Trial

Archives of Ophthalmology

Volumn 109, Issue 9, 1991, Pages 1232-1241

  Hawkins, ^a  

^a Macular Photocoagulation Study Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; LASER COAGULATION; MAJOR CLINICAL STUDY; MALE; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETINA FOVEA; RETINA MACULA AGE RELATED DEGENERATION; VISUAL ACUITY;

AGED; AGED, 80 AND OVER; AGING; CHOROID; COMPARATIVE STUDY; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; FOVEA CENTRALIS; FUNDUS OCULI; HUMAN; LIGHT COAGULATION; MACULAR DEGENERATION; MIDDLE AGE; NEOVASCULARIZATION, PATHOLOGIC; POSTOPERATIVE COMPLICATIONS; RECURRENCE; SUPPORT, U.S. GOV'T, P.H.S.; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 0025887896     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archopht.1991.01080090056026     Document Type: Article

References (15)

1. Macular Photocoagulation Study Group. Recurrent choroidal neovascularization after argon laser photocoagulation for neovascular maculopathy. Arch Ophthalmol. 1986;104:503–512.
2. Macular Photocoagulation Study Group. Persistent and recurrent neovascularization after krypton laser photocoagulation for neovascular lesions of age-related macular degeneration. Arch Ophthalmol. 1990;108:825–831.
3. Macular Photocoagulation Study Group. Persistent and recurrent neovascularization after krypton laser photocoagulation for neovascular lesions of ocular histoplasmosis. Arch Ophthalmol. 1989;107:344–352.
4. Sorenson JA, Yannuzzi LA, Shakin JL. Recurrent subretinal neovascularization. Ophthalmology. 1985;92:1059–1074.
5. Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration: results of a randomized clinical trial. Arch Ophthalmol. 1991;109:1220–1231.
6. Macular Photocoagulation Study Group. Argon laser photocoagulation for senile macular degeneration: results of a randomized clinical trial. Arch Ophthalmol. 1982;100:912–918.
7. Macular Photocoagulation Study Group. Argon laser photocoagulation for ocular histoplasmosis: results of a randomized clinical trial. Arch Ophthalmol. 1983;101:1347–1357.
8. Macular Photocoagulation Study Group. Krypton laser photocoagulation for neovascular lesions of age-related macular degeneration: results of a randomized clinical trial. Arch Ophthalmol. 1990;108:816–824.
9. Macular Photocoagulation Study Group. MPS Manual of Procedures. Springfield, Va: National Technical Information Service; January 1991. Accession No. PB91–159368.
10. Macular Photocoagulation Study Group. Subfoveal neovascular lesions in age-related macular degeneration: guidelines for evaluation and treatment in the Macular Photocoagulation Study. Arch Ophthalmol. 1991;109:1242–1257.
11. Chamberlin JA, Bressler NM, Bressler SB, et al. The use of fundus photographs and fluorescein angiograms in the identification and treatment of choroidal neovascularization in the Macular Photocoagulation Study. Ophthalmology. 1989;96:1526–1534.
12. Brod J, Hilleboe HE, Kimura N, et al. Arterial Hypertension and Ischaemic Heart Disease: Preventive Aspects: Report of an Expert Committee. Geneva, Switzerland: World Health Organization; 1962. Technical Report Series 231.
13. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 1986;42:121–130.
14. Olk RJ, Burgess DB. Treatment of recurrent juxtafoveal subretinal neovascular membranes with krypton red laser photocoagulation. Ophthalmology. 1985;92:1035–1046.
15. Alexander MF, Maguire MG, Lietman TM, Snyder JR, Elman MJ, Fine SL. Assessment of visual function in patients with age-related macular degeneration and low visual acuity. Arch Ophthalmol. 1988;106:1543–1547.